Boule Diagnostics
VC Fund
Spånga, Sweden
Boule Diagnostics is a VC fund in Spånga focused on Medical and Wellness. Boule is a diagnostic company that develops, manufactures and sells systems and consumer products for hematology to non-institutional healthcare. Sales are carried out through a world wide network of distributors, covering more than 100 countries. The company focuses primarily on small and midsize hospitals, clinics and laboratories innon-institutional healthcare, as well as other diagnostic companies in both human and veterinary hematology. Operations are conducted through commercial subsidiaries in Sweden, the US and China.The business was founded in 1992 with the acquisition of Karo Bio Diagnostics AB. But the company’s history goes back to the 1950′s when the founder of Swelab Instrument AB, Erik Öhlin, developed Europe’s first automatic blood cell counter. This is an early predecessor of today’s instruments from Boule. The founders of Boule’s American subsidiary, Clinical Diagnostic Solutions Inc., (CDS) has a similar history from Coulter Corporation which developed the world’s first blood cell counter.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Boule Diagnostics invests in
Stages Boule Diagnostics invests in
Countries Boule Diagnostics invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Investment Focus
Industry
- Medical 1 (100%)
- Wellness 1 (100%)
- Health Care 1 (100%)
- Life Science 1 (100%)
- Biotechnology 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CFO | Total investments: 0 | Find email | ||
|
Erik Öhlin
Founder
|
Founder | Total investments: 0 | Find email | |
Hans Johansson
Senior Vice President of Production
|
Senior Vice President of Production | Total investments: 0 | Find email | |
|
Jesper Söderqvist
CEO and Group President
|
CEO and Group President | Total investments: 0 | Find email | |
Kiarash Farr
Sr Vice President, Commercial Operations
|
Sr Vice President, Commercial Operations | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Biosurfit
|
At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients | $11.3M / Series A / Dec 14, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Boule Diagnostics invest in?
Boule Diagnostics invests primarily in Medical, Wellness and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Portugal. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Boule Diagnostics?
Public channels for Boule Diagnostics include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Boule Diagnostics?
The team at Boule Diagnostics includes Christina Rubenhag (CFO), Erik Öhlin (Founder) and Hans Johansson (Senior Vice President of Production), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
